Rachel Deplus
Impact in
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Genomics and Chromatin Dynamics
- Pluripotent Stem Cells Research
- Glycosylation and Glycoproteins Research
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 19
- RNA modifications and cancer 6
- RNA Research and Splicing 2
- Genomics and Chromatin Dynamics 2
- Cancer-related gene regulation 2
- Pluripotent Stem Cells Research 1
- Co-authors
- François Fuks (16 shared papers)Yvan de Launoit (4 shared papers)Carmen Brenner (3 shared papers)Emmanuelle A. Viré (2 shared papers)David Bernard (2 shared papers)Luciano Di Croce (2 shared papers)Céline Mirjolet (2 shared papers)Manel Esteller (1 shared paper)
- Journals
- The EMBO Journal (4 papers)Oncotarget (2 papers)Nucleic Acids Research (2 papers)Frontiers in Microbiology (1 paper)Nature Structural & Molecular Biology (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Rachel Deplus
25 papers receiving 4.6k citations
Rachel Deplus's Hit Papers
Peers
Comparison fields: 5 of 92
- Molecular Biology 3.4k
- Cancer Research 369
- Hematology 179
- Oncology 253
- Genetics 93
Countries citing papers authored by Rachel Deplus
This map shows the geographic impact of Rachel Deplus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Deplus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Deplus more than expected).
Fields of papers citing papers by Rachel Deplus
This network shows the impact of papers produced by Rachel Deplus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Deplus. The network helps show where Rachel Deplus may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel Deplus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Polycomb group protein EZH2 directly controls DNA methylation Hit paper breakdown → | 2005 | 1807 |
| 2 | 2013 | 412 | |
| 3 | 2008 | 355 | |
| 4 | 2016 | 351 | |
| 5 | 2004 | 348 | |
| 6 | 2012 | 336 | |
| 7 | 2011 | 194 | |
| 8 | 2002 | 163 | |
| 9 | 2014 | 101 | |
| 10 | 2009 | 78 | |
| 11 | 2014 | 69 | |
| 12 | 2021 | 68 | |
| 13 | 2023 | 65 | |
| 14 | 2020 | 64 | |
| 15 | 2015 | 52 | |
| 16 | 2014 | 48 | |
| 17 | 2016 | 42 | |
| 18 | 2015 | 37 | |
| 19 | 2018 | 30 | |
| 20 | 2012 | 25 |
About Rachel Deplus
Rachel Deplus is a scholar working on Molecular Biology, Clinical Biochemistry, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 26 papers that have together received 4.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (19 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (2 papers), Genomics and Chromatin Dynamics (2 papers), Cancer-related gene regulation (2 papers), Prostate Cancer Treatment and Research (2 papers), Pluripotent Stem Cells Research (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Molecular Biology (3.4k citations), Cancer Research (369 citations), Hematology (179 citations), Oncology (253 citations) and Genetics (93 citations). Rachel Deplus has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include François Fuks, Yvan de Launoit, Carmen Brenner, Emmanuelle A. Viré, David Bernard, Luciano Di Croce, Céline Mirjolet, Manel Esteller, Loı̈c Blanchon and Lluís Morey. Their work appears in journals such as The EMBO Journal, Oncotarget, Nucleic Acids Research, Frontiers in Microbiology and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.